tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
Advertisement

AbCellera Biologics (ABCL) Revenue

Compare
2,017 Followers

AbCellera Biologics Revenue

AbCellera Biologics had a revenue of 4.24M in the quarter ending Mar 31, 2025, with -16.14%. This bring the company's revenue in the last twelve months to 2.48M, Increased -56.37%. In the fiscal year ending Dec 31, 2024, AbCellera Biologics had annual revenue of 28.83M with -24.17% growth.
Revenue (ttm)
2.48M
Revenue Growth
-0.54%
P/S Ratio
46.64
Revenue/Employee
$48,378
Employees
596
Market Cap
$1.34B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
28.83M-9.19M-24.17%
Dec 31, 2023
38.02M-447.40M-92.17%
Dec 31, 2022
485.42M110.22M+29.38%
Dec 31, 2021
375.20M142.05M+60.92%
Dec 31, 2020
233.16M221.54M+1,907.96%
Dec 31, 2019
11.61M2.78M+31.49%
Dec 31, 2018
8.83M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis